Taysha Gene Therapies (TSHA) PT Raised to $34 at Wedbush, Following Earnings

August 16, 2021 11:47 AM EDT
Get Alerts TSHA Hot Sheet
Price: $16.98 -0.47%

Rating Summary:
    10 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 5 | Down: 12 | New: 29
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst Laura Chico raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $34.00 (from $33.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Earnings